Prescription drug · ANDA
Acyclovir NDC 72162-1908
Acyclovir 200 mg/1 · Capsule · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72162-1908-0 | 72162190800 | 30 CAPSULE in 1 BOTTLE (72162-1908-0)Marketed from May 8, 2023 | |
| 72162-1908-1 | 72162190801 | 25 CAPSULE in 1 BOTTLE (72162-1908-1)Marketed from May 8, 2023 | |
| 72162-1908-2 | 72162190802 | 35 CAPSULE in 1 BOTTLE (72162-1908-2)Marketed from May 8, 2023 | |
| 72162-1908-3 | 72162190803 | 50 CAPSULE in 1 BOTTLE (72162-1908-3)Marketed from May 8, 2023 | |
| 72162-1908-4 | 72162190804 | 100 CAPSULE in 1 BOTTLE (72162-1908-4)Marketed from May 8, 2023 | |
| 72162-1908-5 | 72162190805 | 40 CAPSULE in 1 BOTTLE (72162-1908-5)Marketed from May 8, 2023 | |
| 72162-1908-6 | 72162190806 | 60 CAPSULE in 1 BOTTLE (72162-1908-6)Marketed from May 8, 2023 | |
| 72162-1908-7 | 72162190807 | 120 CAPSULE in 1 BOTTLE (72162-1908-7)Marketed from May 8, 2023 | |
| 72162-1908-8 | 72162190808 | 20 CAPSULE in 1 BOTTLE (72162-1908-8)Marketed from May 8, 2023 | |
| 72162-1908-9 | 72162190809 | 90 CAPSULE in 1 BOTTLE (72162-1908-9)Marketed from May 8, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acyclovir
- Generic name (nonproprietary)
- acyclovir
- Active ingredients
- Acyclovir — 200 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 075090
- Marketing start
- Listing expires
- Other FDA classes
- DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
- Identifiers
- Product ID 72162-1908_b14c9945-fd73-48e0-af82-302ccf0184ffSPL ID b14c9945-fd73-48e0-af82-302ccf0184ffSPL set ID e8433261-07f1-448b-aaf4-631414598c08RxCUI 197310UNII X4HES1O11F
- Pharmacologic class
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N472162190800followed by a unit qualifier and the quantityPackage 72162-1908-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 075090
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-0280 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-5610 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Florida Pharmaceutical Products, LLC | 71921-146 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Quinn Pharmaceuticals | 69076-146 |
| Acyclovir | Acyclovir 200 mg/1 | CapsuleOral | Proficient Rx LP | 71205-209 |